Ledger.Open graph →
SEC Form D · filed June 27, 2019

DMC Biotechnologies, Inc

Offering
$12.0M
Sold
$4.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Matthew L. Lipscomb · Boulder, COExec · DirectorCarolyn D. Fritz · Boulder, CODirectorMichael D. Lynch · Boulder, CODirectorJosko D. Bobanovic · Boulder, CODirectorRob D. Van Der Meij · Boulder, CODirectorJoseph G. Machado · Boston, MADirectorBrian M. Good · Los Angeles, CADirectorAndrew M. Peltz · Los Angeles, CAExec · DirectorHarlan M. Peltz · Los Angeles, CADirectorCarla R. Hartzenberg · Vancouver, British Columbia, CanadaDirectorRonghui Gu · New York, NYDirectorZhong Shao · New York, NYDirectorMuhan Zou · New York, NYExec · DirectorManivannan Shanmugam · Frisco, TXDirectorBryan A. Helmkamp · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗